Working… Menu
Trial record 1 of 4 for:    Omalizumab | Angio Edema
Previous Study | Return to List | Next Study

Treatment of Idiopathic Angioedema With Xolair as Add-on Therapy

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT02966314
Recruitment Status : Recruiting
First Posted : November 17, 2016
Last Update Posted : November 19, 2019
Novartis Pharmaceuticals
Information provided by (Responsible Party):
University of Wisconsin, Madison

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : March 30, 2020
Estimated Study Completion Date : March 30, 2020